# Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease

> **NCT02055625** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Karolinska Institutet**

## Conditions studied

- Graft -Versus-host-disease

## Interventions

- **BIOLOGICAL:** Mesenchymal stromal cells

## Key facts

- **NCT ID:** NCT02055625
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055625, "Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02055625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*